Ind-Swift Laboratories share news, announcements and annual reports
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Ind-Swift Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1997 on NSE, Mar 2000 on BSE
Last close ₹368.20down ₹41.60 (10.15%)BSE ₹367.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹409.80.
30 Oct: open ₹417.90, high ₹426.60, low ₹352.35
52-week range of traded prices to 30 Oct 2026
₹87.15Low, 31 Dec 2025₹426.60High, 30 Oct 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,202 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.32
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 36,07,65931.1% delivered
Ind-Swift Laboratories board meetings
177 filed, newest first. Page 4 of 4.
Dec 2009
10 Dec · Board meeting
To transact inter-alia among other items the following business: (1) To consider and approve Allotment of 30,00,000 Zero Coupon Convertible Warrants (2009 Series) to Promoter Group Company. (2) Allotment of Shares under Employee Stock Option Plan (ESOP).
Oct 2009
15 Oct · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the second quarter ended September 30, 2009.6 Oct · Board meeting
To consider and approve allotment of 30,00,000 Zero Coupon Convertible Warrants (2009 Series) to Promoter Group Company.
Aug 2009
28 Aug · Board meeting
To consider and approve interalia, among other items, allotment of shares upon part conversion of Zero Coupon Convertible Warrants (SERIES 2008) into equity shares of the holders of the warrants.
Jul 2009
17 Jul · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the first quarter ended June 30, 2009.
Jun 2009
23 Jun · Board meeting
Due to some unavoidable circumstances, the Board Meeting scheduled to be held on June 24, 2009 has been postponed for June 29, 2009 to transact inter-alia among other items the following business: 1) To adopt Annual Audited Accounts for the financial year ended March 31, 2009. 2) To consider declaration of dividend, if any, approved by the Board on the equity shares of the Company.16 Jun · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company have in its meeting held on June 15, 2009, allotted 7,00,000 equity shares of Rs 10/- each at a premium of Rs 60/- per shares to Promoters Group upon the conversion of 7,00,000 Zero Coupon Optionally Convertible Warrants (SERIES 2008).15 Jun · Board meeting
To transact inter-alia among other items the following business : 1) To adopt Annual Audited Accounts for the financial year ended March 31, 2009. 2) To consider declaration of dividend, if any, approved by the Board on the equity shares of the Company.Not held on this date
12 Jun · Board meeting
To consider and approve interalia, among other items , allotment of shares upon part conversion of Zero Coupon Convertible warrants (SERIES 2008) into equity shares of the holders of the warrants.
Jan 2009
9 Jan · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the third quarter ended December 31, 2008.
Oct 2008
8 Oct · Board meeting
Meeting on 25 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Aug 2008
26 Aug · Board meeting
To consider inter-alia among other items allotment of equity shares to promoters Group Company upon conversion of Zero Coupon warrants into equity shares.
Jul 2008
30 Jul · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on July 30, 2008 has approved inter-alia the following: 1) The Board has allotted 3,50,000 equity shares of Rs. 10/- each at a premium of Rs.60/- per share to Promoters Group upon the conversion of 3,50,000 Zero Coupon Optionally Convertible Warrants.17 Jul · Board meeting
To consider inter-alia, Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2008.
Jun 2008
11 Jun · Board meeting
To transact inter-alia among other items the following business: 1) To adopt Annual Audited Accounts for the financial year ended March 31, 2008. 2) To Consider declaration of dividend, if any, approved by the Board on the equity shares of the Company. 3) Allotment of equity shares to promoters Group Companies upon conversion of Zero Coupon Warrants into equity shares.
Mar 2008
17 Mar · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that: "The Board of Directors of the Company have in its meeting held on today i.e. 14th March, 2008 allotted 25,00,000 Zero Coupon Optionally Convertible Warrants (2008 Series) to Promoter Group Company and other Bodies Corporate at a price of Rs. 70/- per warrant".10 Mar · Board meeting
To consider and approve Allotment of 25,00,000 Zero Coupon Convertible Warrants (2008 Series) to Promoter Group Company and other Bodies Corporate at a price of Rs. 70/- per warrant.
Jan 2008
29 Jan · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board has in its meeting held today i.e. January 29, 2008 approved inter-alia the following: 1) The Board has allotted 11,96,000 equity shares to Promoters Group upon the conversion of 11,96,000 Zero Coupon Warrants. 2) A fresh issue of 25,00,000 Zero Coupon optionally Convertible Warrants into Equity Shares to Promoters & other Bodies Corporate at a price of Rs. 70/- per warrants. 3) To convene the Extra Ordinary General Meeting of the shareholders of the Company on February 29, 2008 to seek their approval for the above stated preferential issue. 4) Allotted 1,60,000 options to employees under Employee Stock Option plans of the Company.15 Jan · Board meeting
To consider inter-alia, Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2007.
Oct 2007
19 Oct · Board meeting
Meeting on 29 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Jul 2007
20 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007/Unaudited Financial Results/Dividend/Others”
Apr 2007
24 Apr · Board meeting
Meeting on 30 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Mar 2007
23 Mar · Board meeting
To consider and approve interalia, among other items, part allotment of shares upon conversion of Zero Coupon Convertible warrants into equity shares of the holders of warrants.12 Mar · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that "the Board Meeting of the Company which was earlier scheduled to be held on March 08, 2007, eventually held on March 10, 2007, has allotted 28,00,000 Zero Coupon Convertible warrants on preferential basis to Promoters group Companies".12 Mar · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that "the Board of Directors of the Company have in its meeting held on today i.e. 10th March, 2007, allotted 28,00,000, Zero Coupon Optionally Convertible Warrants into Equity Shares to Promoters Group Companies at a price of Rs.70/- per warrant".5 Mar · Board meeting
For allotment of Convertible warrants on preferential basis to Promoters Group Companies.
Jan 2007
17 Jan · Board meeting
To consider inter-alia, Quarterly Unaudited Financial Results (Provisional) for the quarter ended 31st December, 2006.